SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors rally around the company's optical interconnect technology, with strong bullish sentiment following a CFO interview that dismissed short-seller concerns and highlighted ongoing engagement with hyperscalers. The community is actively discussing the stock's massive trading volume and the potential for a significant re-rating as the company moves toward scaling production and securing major purchase orders.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing significant upward momentum driven by intense retail interest and investor optimism regarding its gallium nitride (GaN) power chip technology, which is viewed as a critical component for future AI data center infrastructure. While bulls are encouraged by potential long-term partnerships and the company's role in next-gen power architectures, the community is actively debating whether this price action is a fundamental re-rating or a speculative short squeeze, with many participants warning of the company's current lack of profitability.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is drawing significant attention as investors await clinical updates and a potential partnership or buyout, following recent institutional stake increases and the presentation of preclinical data for SLS009. The community is deeply divided, with bulls pointing to institutional accumulation and the potential curative nature of their pipeline, while bears voice skepticism regarding the company's financial history and the timeline for trial data releases.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to widespread speculation that a former company executive, Houman Hemmati, is a leading candidate for the FDA's top biologics regulator position. The community is actively discussing how this potential appointment, combined with the company's robust clinical trial data, could accelerate the approval process for their DMD therapy and trigger a significant upward valuation.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing extreme volatility driven by a massive, supply-constrained short squeeze that has left traders debating whether to ride the parabolic momentum toward record highs or brace for an inevitable, sharp correction. The community is deeply polarized, with many retail investors tracking aggressive call flow and institutional concentration, while others warn of a looming 'bagholder' scenario fueled by the company's significant debt and potential for share dilution.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is surging following the release of positive registrational Phase 2 data for miv-cel, with the community highlighting its potential to become the first approved CAR T-cell therapy for autoimmune diseases like stiff-person syndrome. Investors are actively discussing the strong clinical endpoints and future commercialization prospects, while closely watching for potential acquisition interest given the company's strong institutional backing and best-in-class trial results.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi is trending as investors react to the sudden departure of the company's CEO and CFO, a move that has fueled speculation about internal friction and future leadership changes. While the management overhaul has triggered immediate stock volatility, the community is debating whether this leadership reset will ultimately clear a path for signing long-delayed anchor tenants and securing Project Matador's operational future.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is seeing intense investor activity driven by a strategic board overhaul, anticipation of major regulatory de-risking catalysts, and high-conviction institutional accumulation. The community is focused on the company's long-term potential as a critical power provider for AI data centers, while actively monitoring short-interest data and the upcoming criticality milestone for its Aurora reactor.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is gaining momentum as investors eye upcoming catalysts, including a highly anticipated European partnership and potential readouts for its oncology pipeline. With strong institutional ownership and a substantial short interest, market participants are closely monitoring the stock for a potential squeeze as the company transitions from a clinical-stage story to a commercial-stage powerhouse driven by Ibtrozi's rapid adoption.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

The community is actively discussing ProShares Ultra Bloomberg Crude Oil (UCO) amidst extreme volatility in energy markets, fueled by fears of a supply crunch and a potential blockade in the Strait of Hormuz. Investors are intensely debating the impacts of geopolitical tensions on oil prices, with many questioning the efficacy of the ETF's leverage, while others argue that structural supply shortages could drive further upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ARW quietly setting up one of the cleaner charts on my watchlist — but the real question is why is the tape this strong? 
 
Digging in: Arrow isn’t just a “distributor.” They sit at the center of the electronics supply chain — components, enterprise computing, cloud infrastructure, data center solutions. They’re a flow-through for global tech demand. 
 
Think similar lanes as $AVT and $SNX, but $ARW’s positioning across both components + enterprise infra gives it leverage when IT spending stabilizes or re-accelerates. 
 
What stands out: fundamentals are not weak. Margins holding, cash flow solid, and execution consistent despite macro noise. 
 
This isn’t hype-driven AI beta — it’s a picks-and-shovels operator embedded in the system. 
 
When a “boring” name starts printing an exceptional technical structure, it usually means institutions are accumulating before the narrative catches up.

StockTwits Web

Arrow Electronics Inc.

Avnet Inc.

TD Synnex Corp

 quietly setting up one of the cleaner charts on my watchlist — but the real question is why is the tape this strong? 
 
Digging in: Arrow isn’t just a “distributor.” They sit at the center of the electronics supply chain — components, enterprise computing, cloud infrastructure, data center solutions. They’re a flow-through for global tech demand. 
 
Think similar lanes as 

’s positioning across both components + enterprise infra gives it leverage when IT spending stabilizes or re-accelerates. 
 
What stands out: fundamentals are not weak. Margins holding, cash flow solid, and execution consistent despite macro noise. 
 
This isn’t hype-driven AI beta — it’s a picks-and-shovels operator embedded in the system. 
 
When a “boring” name starts printing an exceptional technical structure, it usually means institutions are accumulating before the narrative catches up.